Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Acquisitions (2018 - 2024)

Angiodynamics (ANGO) has disclosed Acquisitions for 11 consecutive years, with $3.2 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Acquisitions changed N/A year-over-year to $3.2 million, compared with a TTM value of $3.8 million through Feb 2024, up 601.85%, and an annual FY2012 reading of $237.9 million, up 21803.04% over the prior year.
  • Acquisitions was $3.2 million for Q1 2024 at Angiodynamics, up from $540000.0 in the prior quarter.
  • Across five years, Acquisitions topped out at $10.0 million in Q1 2020 and bottomed at $540000.0 in Q4 2022.
  • Average Acquisitions over 4 years is $4.3 million, with a median of $3.4 million recorded in 2021.